View More View Less
  • 1 Semmelweis University Institute of Medical Microbiology Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Our group recently demonstrated that diverse fitness cost associated with resistance to fluoroquinolones allowed the extensive dissemination of the major international clones of both methicillin-resistant Staphylococcus aureus (MRSA) and multiresistant Klebsiella pneumoniae in the healthcare setting. The mechanism described by us was subsequently confirmed by British authors investigating the dynamics of MRSA clones in England. Our results imply that the use of fluoroquinolones should impact the incidence for both MRSA and multiresistant K. pneumoniae. A review of the related clinical studies mostly support this notion and shows that changes in the consumption of fluoroquinolone type antibiotics and the rates for both MRSA and multiresistant ESBL-producing K. pneumoniae remain usually in accordance. Though the association seems strong and the mechanism behind it unequivocal the use of fluoroquinolones should not be abandoned; a more judicious application can be recommended.

  • Conceição, T., Aires-de-Sousa, M., Füzi, M., Tóth, Á., Pászti, J., Ungvári, E., van Leeuwen, W.B., van Belkum, A., Grundmann, H., de Lencastre, H.: Replacement of methicillin-resistant Staphylococcus aureus clones in Hungary over time: A 10-year surveillance study. Clin Microbiol Infect 13, 971–979 (2007).

    de Lencastre H. , 'Replacement of methicillin-resistant Staphylococcus aureus clones in Hungary over time: A 10-year surveillance study ' (2007 ) 13 Clin Microbiol Infect : 971 -979.

    • Search Google Scholar
  • Damjanova, I., Tóth, Á., Pászti, J., Bauerfeind, A., Füzi, M.: Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae in Hungary. Eur J Clin Microbiol Infect Dis 25, 275–278 (2006).

    Füzi M. , 'Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae in Hungary ' (2006 ) 25 Eur J Clin Microbiol Infect Dis : 275 -278.

    • Search Google Scholar
  • Damjanova, I., Tóth, Á., Pászti, J., Hajbel-Vékony, G., Jakab, M., Berta, J., Milch, H., Füzi, M.: Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 — the new ‘MRSAs’? J Antimicrob Chemother 62, 978–985 (2008).

    Füzi M. , 'Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 — the new ‘MRSAs’? ' (2008 ) 62 J Antimicrob Chemother : 978 -985.

    • Search Google Scholar
  • Horváth, A., Dobay, O., Kardos, S., Ghidán, Á., Tóth, Á., Pászti, J., Ungvári, E., Horváth, P., Nagy, K., Zissman, S., Füzi, M.: Varying fitness cost associated with resistance to fluoroquinolones governs clonal dynamic of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 31, 2029–2036 (2012).

    Füzi M. , 'Varying fitness cost associated with resistance to fluoroquinolones governs clonal dynamic of methicillin-resistant Staphylococcus aureus ' (2012 ) 31 Eur J Clin Microbiol Infect Dis : 2029 -2036.

    • Search Google Scholar
  • Tóth, Á., Kocsis, B., Damjanova, I., Kristóf, K., Jánvári, L., Pászti, J., Csercsik, R., Topf, J., Szabó, D., Hamar, P., Nagy, K., Füzi, M.: Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended spectrum-β-lactamase. Eur J Clin Microbiol Infect Dis 33, 837–843 (2014).

    Füzi M. , 'Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended spectrum-β-lactamase ' (2014 ) 33 Eur J Clin Microbiol Infect Dis : 837 -843.

    • Search Google Scholar
  • Knight, G.M., Budd, E.L., Whitney, L., Thornley, A., Al-Ghusein, H., Planche, T., Lindsay, J.A.: Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. J Antimicrob Chemother 67, 2514–2522 (2012).

    Lindsay J.A. , 'Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time ' (2012 ) 67 J Antimicrob Chemother : 2514 -2522.

    • Search Google Scholar
  • Hill, D.A., Herford, T., Parratt, D.: Antibiotic usage and methicillin-resistant Staphylococcus aureus: An analysis of causality. J Antimicrob Chemother 42, 676–677 (1998).

    Parratt D. , 'Antibiotic usage and methicillin-resistant Staphylococcus aureus: An analysis of causality ' (1998 ) 42 J Antimicrob Chemother : 676 -677.

    • Search Google Scholar
  • Crowcroft, N.S., Ronveaux, O., Monnet, D.L., Mertens, R.: Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 20, 31–36 (1999).

    Mertens R. , 'Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals ' (1999 ) 20 Infect Control Hosp Epidemiol : 31 -36.

    • Search Google Scholar
  • Gruson, D., Hilbert, G., Vargas, F., Valentino, R., Bebear, C., Allery, A., Bebear, C., Gbikpi-Benissan, G., Cardinaud, J.P.: Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med 162(3 Pt 1), 837–843 (2000).

    Cardinaud J.P. , 'Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria ' (2000 ) 162 Am J Respir Crit Care Med : 837 -843.

    • Search Google Scholar
  • Harbarth, S., Liassine, N., Dharan, S., Herrault, P., Auckenthaler, R., Pittet, D.: Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 31, 1380–1385 (2000).

    Pittet D. , 'Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus ' (2000 ) 31 Clin Infect Dis : 1380 -1385.

    • Search Google Scholar
  • Graffunder, E.M., Venezia, R.A.: Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49, 999–1005 (2002).

    Venezia R.A. , 'Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials ' (2002 ) 49 J Antimicrob Chemother : 999 -1005.

    • Search Google Scholar
  • Weber, S.G., Gold, H.S., Hooper, D.C., Karchmer, A.W., Carmeli, Y.: Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9, 1415–1422 (2003).

    Carmeli Y. , 'Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients ' (2003 ) 9 Emerg Infect Dis : 1415 -1422.

    • Search Google Scholar
  • LeDell, K., Muto, C.A., Jarvis, W.R., Farr, B.M.: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24, 362–386 (2003).

    Farr B.M. , 'SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus ' (2003 ) 24 Infect Control Hosp Epidemiol : 362 -386.

    • Search Google Scholar
  • Nseir, S., Di Pompeo, C., Soubrier, S., Delour, P., Lenci, H., Roussel-Delvallez, M., Onimus, T., Saulnier, F., Mathieu, D., Durocher, A.: First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 3, 283–289 (2005).

    Durocher A. , 'First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit ' (2005 ) 3 Crit Care Med : 283 -289.

    • Search Google Scholar
  • LeBlanc, L., Pepin, J., Toulouse, K., Ouellette, M.F., Coulombe, M.A., Corriveau, M.P., Alary, M.E.: Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 12, 1398–1405 (2006).

    Alary M.E. , 'Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada ' (2006 ) 12 Emerg Infect Dis : 1398 -1405.

    • Search Google Scholar
  • Charbonneau, P., Parienti, J.J., Thibon, P., Ramakers, M., Daubin, C., du Cheyron, D., Lebouvier, G., Le Coutour, X., Leclercq, R., French Fluoroquinolone Free (3F) Study Group: Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: A quasi experimental study. Clin Infect Dis 42, 778–784 (2006).

    Leclercq R. , 'Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: A quasi experimental study ' (2006 ) 42 Clin Infect Dis : 778 -784.

    • Search Google Scholar
  • Madaras-Kelly, K.J., Remington, R.E., Lewis, P.G., Stevens, D.L.: Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 27, 155e–169e (2006).

    Stevens D.L. , 'Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use ' (2006 ) 27 Infect Control Hosp Epidemiol : 155e -169e.

    • Search Google Scholar
  • Muller, A., Mauny, F., Talon, D., Donnan, P.T., Harbarth, S., Bertrand, X.: Effect of individual-and group-level antibiotic exposure on MRSA isolation: A multilevel analysis. J Antimicrob Chemother 58, 878–881 (2006).

    Bertrand X. , 'Effect of individual-and group-level antibiotic exposure on MRSA isolation: A multilevel analysis ' (2006 ) 58 J Antimicrob Chemother : 878 -881.

    • Search Google Scholar
  • Cook, P.P., Catrou, P., Gooch, M., Holbert, D.: Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital. J Hosp Infect 64, 348–351 (2006).

    Holbert D. , 'Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital ' (2006 ) 64 J Hosp Infect : 348 -351.

    • Search Google Scholar
  • Rogues, A.M., Dumartin, C., Amadéo, B., Venier, A.G., Marty, N., Parneix, P., Gachie, J.P.: Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals. Infect Control Hosp Epidemiol 28, 1389–1395 (2007).

    Gachie J.P. , 'Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals ' (2007 ) 28 Infect Control Hosp Epidemiol : 1389 -1395.

    • Search Google Scholar
  • Liebowitz, L.D., Blunt, M.C.: Modification in prescribing practices for third generation cephalosporins and ciprofloxacin is associated with a reduction in meticillin-resistant Staphylococcus aureus bacteraemia rate. Journal of Hospital Infection 69, 328–336 (2008).

    Blunt M.C. , 'Modification in prescribing practices for third generation cephalosporins and ciprofloxacin is associated with a reduction in meticillin-resistant Staphylococcus aureus bacteraemia rate ' (2008 ) 69 Journal of Hospital Infection : 328 -336.

    • Search Google Scholar
  • Aldeyab, M.A., Monnet, D.L., Lopez-Lozano, J.M., Hughes, C.M., Scott, M.G., Kearney, M.P., Magee, F.A., McElnay, J.C.: Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: A time-series analysis. Journal of Antimicrobial Chemotherapy 62, 593–600 (2008).

    McElnay J.C. , 'Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: A time-series analysis ' (2008 ) 62 Journal of Antimicrobial Chemotherapy : 593 -600.

    • Search Google Scholar
  • Vernaz, N., Sax, H., Pittet, D., Bonnabry, P., Schrenzel, J., Harbarth, S.: Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. Journal of Antimicrobial Chemotherapy 62, 601–607 (2008).

    Harbarth S. , 'Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile ' (2008 ) 62 Journal of Antimicrobial Chemotherapy : 601 -607.

    • Search Google Scholar
  • Kaier, K., Hagist, C., Frank, U., Conrad, A., Meyer, E.: Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 30, 346–353 (2009).

    Meyer E. , 'Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection ' (2009 ) 30 Infect Control Hosp Epidemiol : 346 -353.

    • Search Google Scholar
  • Jacoby, T.S., Kuchenbecker, R.S., Dos Santos, R.P., Magedanz, L., Guzatto, P., Moreira, L.B.: Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit. J Hosp Infect 75, 23–27 (2010).

    Moreira L.B. , 'Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit ' (2010 ) 75 J Hosp Infect : 23 -27.

    • Search Google Scholar
  • Thabet, L., Memmi, M., Turki, A., Messadi, A.A.: The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department. Tunis Med 88, 696–699 (2010).

    Messadi A.A. , 'The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department ' (2010 ) 88 Tunis Med : 696 -699.

    • Search Google Scholar
  • Cook, P.P., Rizzo, S., Gooch, M., Jordan, M., Fang, X., Hudson, S.: Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital. J Antimicrob Chemother 66, 205–209 (2011).

    Hudson S. , 'Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital ' (2011 ) 66 J Antimicrob Chemother : 205 -209.

    • Search Google Scholar
  • Huang, S.S., Datta, R., Rifas-Shiman, S., Kleinman, K., Placzek, H., Lankiewicz, J.D., Platt, R.: Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: A nested case-control study. Crit Care 15, R210 (2011).

    Platt R. , 'Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: A nested case-control study ' (2011 ) 15 Crit Care : R210 -.

    • Search Google Scholar
  • Parienti, J.J., Cattoir, V., Thibon, P., Lebouvier, G., Verdon, R., Daubin, C., du Cheyron, D., Leclercq, R., Charbonneau, P.: Hospital-wide modification of fluoroquinolone policy and methicillin-resistant Staphylococcus aureus rates: A 10-year interrupted time-series analysis. J Hosp Infect 78, 118–122 (2011).

    Charbonneau P. , 'Hospital-wide modification of fluoroquinolone policy and methicillin-resistant Staphylococcus aureus rates: A 10-year interrupted time-series analysis ' (2011 ) 78 J Hosp Infect : 118 -122.

    • Search Google Scholar
  • Bertrand, X., Lopez-Lozano, J.M., Slekovec, C., Thouverez, M., Hocquet, D., Talon, D.: Temporal effects of infection control practices and the use of antibiotics on the incidence of MRSA. Journal of Hospital Infection 82, 164–169 (2012).

    Talon D. , 'Temporal effects of infection control practices and the use of antibiotics on the incidence of MRSA ' (2012 ) 82 Journal of Hospital Infection : 164 -169.

    • Search Google Scholar
  • Lafaurie, M., Porcher, R., Donay, J-C., Touratier, S., Molina, J-M.: Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone resistant Pseudomonas aeruginosa isolation rates: A 10-year study. J Antimicrob Chemother 67, 1010–1015 (2012).

    Molina J.-M. , 'Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone resistant Pseudomonas aeruginosa isolation rates: A 10-year study ' (2012 ) 67 J Antimicrob Chemother : 1010 -1015.

    • Search Google Scholar
  • Dancer, S.J., Kirkpatrick, P., Corcoran, D.S., Christison, F., Farmer, D., Robertson, C.: Approaching zero: Temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and methicillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents 41, 137–142 (2013).

    Robertson C. , 'Approaching zero: Temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and methicillin-resistant Staphylococcus aureus ' (2013 ) 41 International Journal of Antimicrobial Agents : 137 -142.

    • Search Google Scholar
  • Aubert, G., Carricajo, A., Vautrin, A.C., Guyomarc’h, S., Fonsale, N., Page, D., Brunel, P., Rusch, P., Zéni, F.: Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit. J Hosp Infect 59, 83–89 (2005).

    Zéni F. , 'Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit ' (2005 ) 59 J Hosp Infect : 83 -89.

    • Search Google Scholar
  • Wibbenmeyer, L., Williams, I., Ward, M., Xiao, X., Light, T., Latenser, B., Lewis, R., Kealey, G.P., Herwaldt, L.: Risk factors for acquiring vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus on a burn surgery step-down unit. J Burn Care Res 31, 269–279 (2010).

    Herwaldt L. , 'Risk factors for acquiring vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus on a burn surgery step-down unit ' (2010 ) 31 J Burn Care Res : 269 -279.

    • Search Google Scholar
  • Datta, R., Kleinman, K., Rifas-Shiman, S., Placzek, H., Lankiewicz, J., Platt, R., Huang, S.S.: Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition. Antimicrob Resist Infect Control 2014 Jun 1;3:19. doi: 10.1186/2047-2994-3-19

    Huang S.S. , 'Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition ' (2014 ) 3 Antimicrob Resist Infect Control : 19 -.

    • Search Google Scholar
  • MacDougall, C., Harpe, S.E., Powell, J.P., Johnson, C.K., Edmond, M.B., Polk, R.E.: Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerg Infect Dis 11, 1197–1204 (2005).

    Polk R.E. , 'Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use ' (2005 ) 11 Emerg Infect Dis : 1197 -1204.

    • Search Google Scholar
  • Bosso, J.A., Mauldin, P.D.: Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of Gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 50, 2106–2112 (2006).

    Mauldin P.D. , 'Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of Gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus ' (2006 ) 50 Antimicrob Agents Chemother : 2106 -2112.

    • Search Google Scholar
  • Salangsang, J.A., Harrison, L.H., Brooks, M.M., Shutt, K.A., Saul, M.I., Muto, C.A.: Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Infect Control Hosp Epidemiol 31, 1139–1147 (2010).

    Muto C.A. , 'Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospital ' (2010 ) 31 Infect Control Hosp Epidemiol : 1139 -1147.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 11 1 2
Mar 2021 9 0 0
Apr 2021 5 0 0
May 2021 8 0 0
Jun 2021 3 0 0
Jul 2021 5 0 0
Aug 2021 0 0 0